Immunosuppressive treatment of multiple sclerosis.
This article has reviewed some of the principles of the immune basis of multiple sclerosis and one potential therapy: cyclophosphamide and corticotropin. Although some of the studies with this combination present encouraging findings, these must be carefully evaluated. This approach is still experimental and the long-term effects of therapy are still to be evaluated. The neuroscience nurse has an important place in this research. Not only should the nurse be a critical consumer of the research investigating these protocols, but she must also use unique nursing skills to assist the patient while undergoing the therapy.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing
D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone